Rare diseases
Investigational molecules
Locations
Back to Italy36 clinical trials in Castelfranco Veneto, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of tazemetostat combined with lenalidomide and rituximab in adult patients with relapsed or refractory follicular lymphoma
ItalyStudy on Radiotherapy Alone or with Obinutuzumab for Patients with Early Stage Follicular Lymphoma
ItalyStudy Comparing Mosunetuzumab and Lenalidomide with Other Treatments for Patients with Relapsed or Refractory Marginal Zone Lymphoma
ItalyTambiciclib Added to Venetoclax and Azacitidine for Newly Diagnosed Acute Myeloid Leukemia in Patients Who Did Not Respond After Two Treatment Cycles
ItalyA study to evaluate the use of colchicine to reduce inflammation in patients with deep vein thrombosis.
ItalyStudy on Pirfenidone for Preventing Lung Fibrosis in Patients with Acute Respiratory Distress Syndrome (ARDS)
ItalyStudy on Sulodexide for Preventing Recurrence of Blood Clots in Elderly Patients After First Episode of Deep Vein Thrombosis or Pulmonary Embolism
ItalyStudy on Durvalumab with Chemotherapy for Patients with Advanced Biliary Tract Cancer
ItalyStudy on Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma Not Eligible for Transplant
ItalyStudy of Retifanlimab Combined with Carboplatin, Cisplatin and Etoposide Before Surgery in Patients with Resectable Merkel Cell Carcinoma
ItalyStudy on the Effectiveness and Safety of Ibrutinib with Rituximab-CHOP for Untreated Patients with Diffuse Large B-cell Lymphoma at High Risk
ItalyStudy Comparing Shortened vs Standard Chemotherapy with Rituximab for Initial Treatment of High Tumor Burden Follicular Lymphoma in Newly Diagnosed Patients
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking research focusing on blood-related cancers, including studies of Acute Myeloid Leukemia, Follicular Lymphoma, and Chronic Myeloid Leukemia. Clinical trials are evaluating innovative combination therapies and maintenance treatments.
Multiple trials are investigating immunotherapy approaches and targeted treatments to improve patient outcomes.
Studies addressing peripheral arterial disease and vascular complications. Research includes innovative approaches using established medications for new cardiovascular applications.
Trials focus on reducing major cardiovascular events and improving long-term patient outcomes.
Research initiatives targeting various solid tumors, including bladder cancer and biliary tract cancers. Studies are evaluating combination approaches with immunotherapy and conventional treatments.
Emphasis on developing more effective and less toxic treatment options for cancer patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
